首页> 外文会议>2011 IEEE International Conference on Systems Biology >MicroRNA expression analysis reveals significant biological pathways in human prostate cancer
【24h】

MicroRNA expression analysis reveals significant biological pathways in human prostate cancer

机译:MicroRNA表达分析揭示了人类前列腺癌的重要生物学途径

获取原文

摘要

MicroRNAs (miRNAs) are reported to play essential roles in cancer initiation and progression and microarray technologies are intensively applied to study the miRNA expression profile in cancer. It is very common that the set of differentially expressed miRNAs related to the same cancer identified from different laboratories varies widely. Meanwhile, how the altered miRNAs coordinately contribute to the cause of prostate cancer is still not clear. In this study, we collected and processed four human prostate cancer associated miRNA microarray expression datasets with newly developed cancer outlier detection methods to identify differentially expressed miRNAs (DE-miRNAs). The targets of these DE-miRNAs were then extracted from database or predicted by bioinformatics prediction and then mapped to functional databases for enrichment analysis and overlapping comparison. Newly developed outlier detection methods were found to be more appropriate than t-test in cancer research, and the consistency of independent prostate cancer expression profiles at pathway or gene-set level was shown higher than that at gene (i.e. miRNA here) level. Furthermore, we identified 41 Gene Ontology terms, 4 KEGG pathways and 77 GeneGO pathways which are associated with prostate cancer. Among the top 15 GeneGO pathways, 5 were reported previously and the rest could be putative ones. Our analyses showed that more appropriate outlier detection methods should be used to detect oncogenes or oncomiRNAs that are altered only in a subset of samples. We proved that expression signatures of independent microarray experiments are more consistent rather at pathway level than at miRNA / gene level. We also found that the utilization of similar meta-analysis methods between miRNA and mRNA profiling datasets result in the detection of the same pathways.
机译:据报道,微小RNA(miRNA)在癌症的发生和发展中起着至关重要的作用,微阵列技术被广泛应用于研究癌症中miRNA的表达谱。从不同实验室鉴定出的与同一癌症相关的差异表达的miRNA的集合差异很大,这是非常普遍的。同时,尚不清楚改变的miRNA如何协同促成前列腺癌的起因。在这项研究中,我们使用新开发的癌症离群值检测方法收集和处理了四个与人类前列腺癌相关的miRNA微阵列表达数据集,以鉴定差异表达的miRNA(DE-miRNA)。然后从数据库中提取这些DE-miRNA的靶标,或通过生物信息学预测对其进行预测,然后将其映射到功能数据库中进行富集分析和重叠比较。在癌症研究中,发现新开发的离群值检测方法比t检验更合适,并且在途径或基因组水平上独立的前列腺癌表达谱的一致性显示出高于基因(即此处的miRNA)水平。此外,我们确定了与前列腺癌相关的41个基因本体论术语,4个KEGG途径和77个GeneGO途径。在最重要的15条GeneGO途径中,先前报道了5条,其余可能是假定途径。我们的分析表明,应使用更合适的异常值检测方法来检测仅在一部分样本中发生改变的癌基因或癌基因RNA。我们证明了独立微阵列实验的表达特征比在miRNA /基因水平上更一致,而不是在途径水平上。我们还发现,利用miRNA和mRNA分析数据集之间相似的荟萃分析方法可以检测到相同的途径。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号